
FasterCures Quarterly Update: July 2023

A Letter from FasterCures' Executive Director Esther Krofah

Lessons Learned From COVID-19: Are There Silver Linings for Biomedical Innovation?

Pandemic and All-Hazards Preparedness Act (PAHPA) Policy Brief

Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870
